{"entity":{"type":"insider","cik":"0001374150","url":"/insider/0001374150","json_url":"/insider/0001374150.json","name":"DOMAIN PARTERS VII L P","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":79,"n_filings":50,"first":"2008-12-11","last":"2019-08-08","span_basis":"filed_date"},"name_variants":[{"name":"DOMAIN PARTERS VII L P","source":"filing","n_filings":50,"first_seen":"2008-12-11","last_seen":"2019-08-08"}],"transactions":[{"id":8472765,"accession":"0000904454-19-000600","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-19-000600","line_url":"/filing/0000904454-19-000600#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"OBALON THERAPEUTICS INC","issuer_ticker":"OBLN","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DOVEY BRIAN H; TREU JESSE I; BLAIR JAMES C; VITULLO NICOLE; Halak Brian K; DOMAIN PARTERS VII L P","owner_display_name":"DOVEY BRIAN H","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":250000.0,"shares_display":"250,000","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":1000000.0,"total_display":"1,000,000.00","total_whole":"1,000,000","shares_owned_after":813433.0,"shares_owned_after_display":"813,433","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-06","filed_date":"2019-08-08","scope":"insider"},{"id":6436667,"accession":"0000904454-18-000526","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-18-000526","line_url":"/filing/0000904454-18-000526#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"OBALON THERAPEUTICS INC","issuer_ticker":"OBLN","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"Halak Brian K; DOVEY BRIAN H; TREU JESSE I; DOMAIN PARTERS VII L P; BLAIR JAMES C; VITULLO NICOLE","owner_display_name":"Halak Brian K","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1648359.0,"shares_display":"1,648,359","price_per_share":1.82,"price_display":"1.82","price_state":"stated","total_value":3000013.38,"total_display":"3,000,013.38","total_whole":"3,000,013","shares_owned_after":5634329.0,"shares_owned_after_display":"5,634,329","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-08-23","filed_date":"2018-08-27","scope":"insider"},{"id":2080165,"accession":"0000904454-16-001235","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-16-001235","line_url":"/filing/0000904454-16-001235#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DOVEY BRIAN H; Halak Brian K; DOMAIN PARTERS VII L P; BLAIR JAMES C; VITULLO NICOLE; TREU JESSE I","owner_display_name":"DOVEY BRIAN H","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":344120.0,"shares_display":"344,120","price_per_share":4.7,"price_display":"4.70","price_state":"stated","total_value":1617364.0,"total_display":"1,617,364.00","total_whole":"1,617,364","shares_owned_after":606283.0,"shares_owned_after_display":"606,283","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-05-26","filed_date":"2016-05-27","scope":"insider"},{"id":2863423,"accession":"0000904454-16-001187","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-16-001187","line_url":"/filing/0000904454-16-001187#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"VITULLO NICOLE; DOMAIN PARTERS VII L P; DOVEY BRIAN H; TREU JESSE I; BLAIR JAMES C; Halak Brian K","owner_display_name":"VITULLO NICOLE","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3603.0,"shares_display":"3,603","price_per_share":5.02,"price_display":"5.02","price_state":"stated","total_value":18087.06,"total_display":"18,087.06","total_whole":"18,087","shares_owned_after":950403.0,"shares_owned_after_display":"950,403","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-27","filed_date":"2016-04-27","scope":"insider"},{"id":2863417,"accession":"0000904454-16-001187","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-16-001187","line_url":"/filing/0000904454-16-001187#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"VITULLO NICOLE; DOMAIN PARTERS VII L P; DOVEY BRIAN H; TREU JESSE I; BLAIR JAMES C; Halak Brian K","owner_display_name":"VITULLO NICOLE","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1492.0,"shares_display":"1,492","price_per_share":5.2,"price_display":"5.20","price_state":"stated","total_value":7758.4,"total_display":"7,758.40","total_whole":"7,758","shares_owned_after":954006.0,"shares_owned_after_display":"954,006","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-25","filed_date":"2016-04-27","scope":"insider"},{"id":2311053,"accession":"0000904454-16-001170","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-16-001170","line_url":"/filing/0000904454-16-001170#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DOVEY BRIAN H; VITULLO NICOLE; DOMAIN PARTERS VII L P; BLAIR JAMES C; Halak Brian K; TREU JESSE I","owner_display_name":"DOVEY BRIAN H","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4424.0,"shares_display":"4,424","price_per_share":5.29,"price_display":"5.29","price_state":"stated","total_value":23402.96,"total_display":"23,402.96","total_whole":"23,403","shares_owned_after":955498.0,"shares_owned_after_display":"955,498","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-20","filed_date":"2016-04-21","scope":"insider"},{"id":2311047,"accession":"0000904454-16-001170","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-16-001170","line_url":"/filing/0000904454-16-001170#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DOVEY BRIAN H; VITULLO NICOLE; DOMAIN PARTERS VII L P; BLAIR JAMES C; Halak Brian K; TREU JESSE I","owner_display_name":"DOVEY BRIAN H","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37054.0,"shares_display":"37,054","price_per_share":5.36,"price_display":"5.36","price_state":"stated","total_value":198609.44,"total_display":"198,609.44","total_whole":"198,609","shares_owned_after":959922.0,"shares_owned_after_display":"959,922","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-19","filed_date":"2016-04-21","scope":"insider"},{"id":2268807,"accession":"0000904454-16-001164","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-16-001164","line_url":"/filing/0000904454-16-001164#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"Halak Brian K; TREU JESSE I; DOVEY BRIAN H; BLAIR JAMES C; VITULLO NICOLE; DOMAIN PARTERS VII L P","owner_display_name":"Halak Brian K","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4348.0,"shares_display":"4,348","price_per_share":5.22,"price_display":"5.22","price_state":"stated","total_value":22696.56,"total_display":"22,696.56","total_whole":"22,697","shares_owned_after":996976.0,"shares_owned_after_display":"996,976","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-11","filed_date":"2016-04-13","scope":"insider"},{"id":2903334,"accession":"0000904454-16-001154","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000904454-16-001154","line_url":"/filing/0000904454-16-001154#line-3","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DOMAIN PARTERS VII L P; BLAIR JAMES C; Halak Brian K; TREU JESSE I; DOVEY BRIAN H; VITULLO NICOLE","owner_display_name":"DOMAIN PARTERS VII L P","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14554.0,"shares_display":"14,554","price_per_share":5.35,"price_display":"5.35","price_state":"stated","total_value":77863.9,"total_display":"77,863.90","total_whole":"77,864","shares_owned_after":1001324.0,"shares_owned_after_display":"1,001,324","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-08","filed_date":"2016-04-08","scope":"insider"},{"id":2903328,"accession":"0000904454-16-001154","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-16-001154","line_url":"/filing/0000904454-16-001154#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DOMAIN PARTERS VII L P; BLAIR JAMES C; Halak Brian K; TREU JESSE I; DOVEY BRIAN H; VITULLO NICOLE","owner_display_name":"DOMAIN PARTERS VII L P","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27781.0,"shares_display":"27,781","price_per_share":5.26,"price_display":"5.26","price_state":"stated","total_value":146128.06,"total_display":"146,128.06","total_whole":"146,128","shares_owned_after":1015878.0,"shares_owned_after_display":"1,015,878","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-07","filed_date":"2016-04-08","scope":"insider"},{"id":2903320,"accession":"0000904454-16-001154","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-16-001154","line_url":"/filing/0000904454-16-001154#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DOMAIN PARTERS VII L P; BLAIR JAMES C; Halak Brian K; TREU JESSE I; DOVEY BRIAN H; VITULLO NICOLE","owner_display_name":"DOMAIN PARTERS VII L P","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":6,"other_reporting_owners":5,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8669.0,"shares_display":"8,669","price_per_share":5.22,"price_display":"5.22","price_state":"stated","total_value":45252.18,"total_display":"45,252.18","total_whole":"45,252","shares_owned_after":1043659.0,"shares_owned_after_display":"1,043,659","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-06","filed_date":"2016-04-08","scope":"insider"},{"id":8653651,"accession":"0000904454-15-000536","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-15-000536","line_url":"/filing/0000904454-15-000536#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; DOVEY BRIAN H; SCHOEMAKER KATHLEEN K; DOMAIN PARTERS VII L P; Halak Brian K; TREU JESSE I; VITULLO NICOLE","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11836.0,"shares_display":"11,836","price_per_share":7.02,"price_display":"7.02","price_state":"stated","total_value":83088.72,"total_display":"83,088.72","total_whole":"83,089","shares_owned_after":1052328.0,"shares_owned_after_display":"1,052,328","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-08-18","filed_date":"2015-08-20","scope":"insider"},{"id":8125638,"accession":"0000904454-15-000262","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-15-000262","line_url":"/filing/0000904454-15-000262#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Regado Biosciences Inc","issuer_ticker":"TBRA","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DOVEY BRIAN H; TREU JESSE I; Halak Brian K; DOMAIN PARTERS VII L P; BLAIR JAMES C; SCHOEMAKER KATHLEEN K; VITULLO NICOLE","owner_display_name":"DOVEY BRIAN H","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":277777.0,"shares_display":"277,777","price_per_share":10.62,"price_display":"10.62","price_state":"stated","total_value":2949991.74,"total_display":"2,949,991.74","total_whole":"2,949,992","shares_owned_after":3553322.0,"shares_owned_after_display":"3,553,322","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-05-04","filed_date":"2015-05-06","scope":"insider"},{"id":8048899,"accession":"0000904454-15-000246","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000904454-15-000246","line_url":"/filing/0000904454-15-000246#line-3","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DOVEY BRIAN H; Halak Brian K; SCHOEMAKER KATHLEEN K; VITULLO NICOLE; DOMAIN PARTERS VII L P; BLAIR JAMES C; TREU JESSE I","owner_display_name":"DOVEY BRIAN H","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32411.0,"shares_display":"32,411","price_per_share":7.07,"price_display":"7.07","price_state":"stated","total_value":229145.77,"total_display":"229,145.77","total_whole":"229,146","shares_owned_after":1064164.0,"shares_owned_after_display":"1,064,164","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-16","filed_date":"2015-04-16","scope":"insider"},{"id":8048897,"accession":"0000904454-15-000246","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-15-000246","line_url":"/filing/0000904454-15-000246#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DOVEY BRIAN H; Halak Brian K; SCHOEMAKER KATHLEEN K; VITULLO NICOLE; DOMAIN PARTERS VII L P; BLAIR JAMES C; TREU JESSE I","owner_display_name":"DOVEY BRIAN H","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7920.0,"shares_display":"7,920","price_per_share":7.58,"price_display":"7.58","price_state":"stated","total_value":60033.6,"total_display":"60,033.60","total_whole":"60,034","shares_owned_after":1096575.0,"shares_owned_after_display":"1,096,575","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-15","filed_date":"2015-04-16","scope":"insider"},{"id":8048892,"accession":"0000904454-15-000246","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-15-000246","line_url":"/filing/0000904454-15-000246#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Evoke Pharma Inc","issuer_ticker":"EVOK","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DOVEY BRIAN H; Halak Brian K; SCHOEMAKER KATHLEEN K; VITULLO NICOLE; DOMAIN PARTERS VII L P; BLAIR JAMES C; TREU JESSE I","owner_display_name":"DOVEY BRIAN H","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9832.0,"shares_display":"9,832","price_per_share":7.78,"price_display":"7.78","price_state":"stated","total_value":76492.96,"total_display":"76,492.96","total_whole":"76,493","shares_owned_after":1104495.0,"shares_owned_after_display":"1,104,495","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-14","filed_date":"2015-04-16","scope":"insider"},{"id":9206232,"accession":"0000904454-14-000789","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-14-000789","line_url":"/filing/0000904454-14-000789#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Neothetics, Inc.","issuer_ticker":"NEOT","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; DOMAIN PARTERS VII L P; DOVEY BRIAN H; Halak Brian K; SCHOEMAKER KATHLEEN K; TREU JESSE I; VITULLO NICOLE","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":70000.0,"shares_display":"70,000","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":980000.0,"total_display":"980,000.00","total_whole":"980,000","shares_owned_after":3091643.0,"shares_owned_after_display":"3,091,643","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-25","filed_date":"2014-12-10","scope":"insider"},{"id":6480876,"accession":"0000904454-14-000771","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0000904454-14-000771","line_url":"/filing/0000904454-14-000771#line-6","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Neothetics, Inc.","issuer_ticker":"NEOT","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DOVEY BRIAN H; Halak Brian K; SCHOEMAKER KATHLEEN K; TREU JESSE I; VITULLO NICOLE; BLAIR JAMES C; DOMAIN PARTERS VII L P","owner_display_name":"DOVEY BRIAN H","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":70000.0,"shares_display":"70,000","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":980000.0,"total_display":"980,000.00","total_whole":"980,000","shares_owned_after":3091642.0,"shares_owned_after_display":"3,091,642","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-25","filed_date":"2014-11-26","scope":"insider"},{"id":6275307,"accession":"0000904454-14-000723","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-14-000723","line_url":"/filing/0000904454-14-000723#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"TREU JESSE I; VITULLO NICOLE; BLAIR JAMES C; Halak Brian K; DOMAIN PARTERS VII L P; SCHOEMAKER KATHLEEN K; DOVEY BRIAN H","owner_display_name":"TREU JESSE I","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500000.0,"shares_display":"500,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":10000000.0,"total_display":"10,000,000.00","total_whole":"10,000,000","shares_owned_after":2566935.0,"shares_owned_after_display":"2,566,935","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-21","filed_date":"2014-10-21","scope":"insider"},{"id":5095912,"accession":"0000904454-13-000768","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000768","line_url":"/filing/0000904454-13-000768#line-2","is_derivative":false,"issuer_cik":"0001374150","issuer_name":"Esperion Therapeutics, Inc.","issuer_ticker":"ESPR","issuer_name_source":null,"issuer_url":"/issuer/0001374150","owner_cik":"0001374150","owner_name":"DOMAIN PARTERS VII L P","owner_display_name":"DOMAIN PARTERS VII L P","owner_url":"/insider/0001374150","role":"Ten percent owner","role_mark":"%","role_mark_label":"Ten percent owner","role_mark_generic":"Ten percent owner","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":280923.0,"shares_display":"280,923","price_per_share":14.0,"price_display":"14.00","price_state":"stated","total_value":3932922.0,"total_display":"3,932,922.00","total_whole":"3,932,922","shares_owned_after":2066935.0,"shares_owned_after_display":"2,066,935","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-07-01","filed_date":"2013-07-02","scope":"insider"},{"id":4475322,"accession":"0000904454-13-000661","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000661","line_url":"/filing/0000904454-13-000661#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DOMAIN PARTERS VII L P; DOVEY BRIAN H; Halak Brian K; VITULLO NICOLE; SCHOEMAKER KATHLEEN K; BLAIR JAMES C; TREU JESSE I","owner_display_name":"DOMAIN PARTERS VII L P","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":159192.0,"shares_display":"159,192","price_per_share":64.58,"price_display":"64.58","price_state":"stated","total_value":10280619.36,"total_display":"10,280,619.36","total_whole":"10,280,619","shares_owned_after":2581745.0,"shares_owned_after_display":"2,581,745","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-06-04","filed_date":"2013-06-05","scope":"insider"},{"id":4956318,"accession":"0000904454-13-000494","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000494","line_url":"/filing/0000904454-13-000494#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DOVEY BRIAN H; VITULLO NICOLE; BLAIR JAMES C; DOMAIN PARTERS VII L P; SCHOEMAKER KATHLEEN K; Halak Brian K; TREU JESSE I","owner_display_name":"DOVEY BRIAN H","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":23210.0,"shares_display":"23,210","price_per_share":6.62,"price_display":"6.62","price_state":"stated","total_value":153650.2,"total_display":"153,650.20","total_whole":"153,650","shares_owned_after":2371190.0,"shares_owned_after_display":"2,371,190","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-15","filed_date":"2013-04-17","scope":"insider"},{"id":4380595,"accession":"0000904454-13-000490","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000904454-13-000490","line_url":"/filing/0000904454-13-000490#line-3","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; TREU JESSE I; SCHOEMAKER KATHLEEN K; VITULLO NICOLE; Halak Brian K; DOMAIN PARTERS VII L P; DOVEY BRIAN H","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1567.0,"shares_display":"1,567","price_per_share":6.72,"price_display":"6.72","price_state":"stated","total_value":10530.24,"total_display":"10,530.24","total_whole":"10,530","shares_owned_after":2394400.0,"shares_owned_after_display":"2,394,400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-10","filed_date":"2013-04-10","scope":"insider"},{"id":4380592,"accession":"0000904454-13-000490","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000490","line_url":"/filing/0000904454-13-000490#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; TREU JESSE I; SCHOEMAKER KATHLEEN K; VITULLO NICOLE; Halak Brian K; DOMAIN PARTERS VII L P; DOVEY BRIAN H","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11386.0,"shares_display":"11,386","price_per_share":6.71,"price_display":"6.71","price_state":"stated","total_value":76400.06,"total_display":"76,400.06","total_whole":"76,400","shares_owned_after":2395967.0,"shares_owned_after_display":"2,395,967","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-09","filed_date":"2013-04-10","scope":"insider"},{"id":4380588,"accession":"0000904454-13-000490","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000490","line_url":"/filing/0000904454-13-000490#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; TREU JESSE I; SCHOEMAKER KATHLEEN K; VITULLO NICOLE; Halak Brian K; DOMAIN PARTERS VII L P; DOVEY BRIAN H","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12217.0,"shares_display":"12,217","price_per_share":6.52,"price_display":"6.52","price_state":"stated","total_value":79654.84,"total_display":"79,654.84","total_whole":"79,655","shares_owned_after":2407353.0,"shares_owned_after_display":"2,407,353","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-04-08","filed_date":"2013-04-10","scope":"insider"},{"id":5349915,"accession":"0000904454-13-000473","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000473","line_url":"/filing/0000904454-13-000473#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DOVEY BRIAN H; BLAIR JAMES C; VITULLO NICOLE; TREU JESSE I; SCHOEMAKER KATHLEEN K; DOMAIN PARTERS VII L P; Halak Brian K","owner_display_name":"DOVEY BRIAN H","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4374.0,"shares_display":"4,374","price_per_share":5.35,"price_display":"5.35","price_state":"stated","total_value":23400.9,"total_display":"23,400.90","total_whole":"23,401","shares_owned_after":2419570.0,"shares_owned_after_display":"2,419,570","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-21","filed_date":"2013-03-22","scope":"insider"},{"id":5145853,"accession":"0000904454-13-000455","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000455","line_url":"/filing/0000904454-13-000455#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DOMAIN PARTERS VII L P; TREU JESSE I; Halak Brian K; VITULLO NICOLE; BLAIR JAMES C; SCHOEMAKER KATHLEEN K; DOVEY BRIAN H","owner_display_name":"DOMAIN PARTERS VII L P","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5510.0,"shares_display":"5,510","price_per_share":5.22,"price_display":"5.22","price_state":"stated","total_value":28762.2,"total_display":"28,762.20","total_whole":"28,762","shares_owned_after":2423944.0,"shares_owned_after_display":"2,423,944","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-20","filed_date":"2013-03-21","scope":"insider"},{"id":5145847,"accession":"0000904454-13-000455","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000455","line_url":"/filing/0000904454-13-000455#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DOMAIN PARTERS VII L P; TREU JESSE I; Halak Brian K; VITULLO NICOLE; BLAIR JAMES C; SCHOEMAKER KATHLEEN K; DOVEY BRIAN H","owner_display_name":"DOMAIN PARTERS VII L P","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7925.0,"shares_display":"7,925","price_per_share":5.19,"price_display":"5.19","price_state":"stated","total_value":41130.75,"total_display":"41,130.75","total_whole":"41,131","shares_owned_after":2429454.0,"shares_owned_after_display":"2,429,454","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-19","filed_date":"2013-03-21","scope":"insider"},{"id":5435126,"accession":"0000904454-13-000445","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000445","line_url":"/filing/0000904454-13-000445#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; DOVEY BRIAN H; VITULLO NICOLE; Halak Brian K; SCHOEMAKER KATHLEEN K; DOMAIN PARTERS VII L P; TREU JESSE I","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8020.0,"shares_display":"8,020","price_per_share":5.16,"price_display":"5.16","price_state":"stated","total_value":41383.2,"total_display":"41,383.20","total_whole":"41,383","shares_owned_after":2437379.0,"shares_owned_after_display":"2,437,379","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-18","filed_date":"2013-03-19","scope":"insider"},{"id":5435122,"accession":"0000904454-13-000445","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000445","line_url":"/filing/0000904454-13-000445#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; DOVEY BRIAN H; VITULLO NICOLE; Halak Brian K; SCHOEMAKER KATHLEEN K; DOMAIN PARTERS VII L P; TREU JESSE I","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9636.0,"shares_display":"9,636","price_per_share":5.28,"price_display":"5.28","price_state":"stated","total_value":50878.08,"total_display":"50,878.08","total_whole":"50,878","shares_owned_after":2445399.0,"shares_owned_after_display":"2,445,399","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-15","filed_date":"2013-03-19","scope":"insider"},{"id":4902334,"accession":"0000904454-13-000435","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000435","line_url":"/filing/0000904454-13-000435#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"TREU JESSE I; SCHOEMAKER KATHLEEN K; Halak Brian K; VITULLO NICOLE; BLAIR JAMES C; DOVEY BRIAN H; DOMAIN PARTERS VII L P","owner_display_name":"TREU JESSE I","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5020.0,"shares_display":"5,020","price_per_share":5.36,"price_display":"5.36","price_state":"stated","total_value":26907.2,"total_display":"26,907.20","total_whole":"26,907","shares_owned_after":2455035.0,"shares_owned_after_display":"2,455,035","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-14","filed_date":"2013-03-15","scope":"insider"},{"id":4902328,"accession":"0000904454-13-000435","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000435","line_url":"/filing/0000904454-13-000435#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"TREU JESSE I; SCHOEMAKER KATHLEEN K; Halak Brian K; VITULLO NICOLE; BLAIR JAMES C; DOVEY BRIAN H; DOMAIN PARTERS VII L P","owner_display_name":"TREU JESSE I","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7733.0,"shares_display":"7,733","price_per_share":5.4,"price_display":"5.40","price_state":"stated","total_value":41758.2,"total_display":"41,758.20","total_whole":"41,758","shares_owned_after":2460055.0,"shares_owned_after_display":"2,460,055","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-13","filed_date":"2013-03-15","scope":"insider"},{"id":4217046,"accession":"0000904454-13-000427","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000427","line_url":"/filing/0000904454-13-000427#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; SCHOEMAKER KATHLEEN K; Halak Brian K; VITULLO NICOLE; TREU JESSE I; DOMAIN PARTERS VII L P; DOVEY BRIAN H","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6346.0,"shares_display":"6,346","price_per_share":5.38,"price_display":"5.38","price_state":"stated","total_value":34141.48,"total_display":"34,141.48","total_whole":"34,141","shares_owned_after":2467788.0,"shares_owned_after_display":"2,467,788","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-12","filed_date":"2013-03-13","scope":"insider"},{"id":4217041,"accession":"0000904454-13-000427","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000427","line_url":"/filing/0000904454-13-000427#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; SCHOEMAKER KATHLEEN K; Halak Brian K; VITULLO NICOLE; TREU JESSE I; DOMAIN PARTERS VII L P; DOVEY BRIAN H","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4118.0,"shares_display":"4,118","price_per_share":5.34,"price_display":"5.34","price_state":"stated","total_value":21990.12,"total_display":"21,990.12","total_whole":"21,990","shares_owned_after":2474134.0,"shares_owned_after_display":"2,474,134","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-11","filed_date":"2013-03-13","scope":"insider"},{"id":4956280,"accession":"0000904454-13-000399","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000399","line_url":"/filing/0000904454-13-000399#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"SCHOEMAKER KATHLEEN K; DOMAIN PARTERS VII L P; BLAIR JAMES C; DOVEY BRIAN H; TREU JESSE I; Halak Brian K; VITULLO NICOLE","owner_display_name":"SCHOEMAKER KATHLEEN K","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5154.0,"shares_display":"5,154","price_per_share":5.32,"price_display":"5.32","price_state":"stated","total_value":27419.28,"total_display":"27,419.28","total_whole":"27,419","shares_owned_after":2478252.0,"shares_owned_after_display":"2,478,252","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-08","filed_date":"2013-03-11","scope":"insider"},{"id":4956277,"accession":"0000904454-13-000399","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000399","line_url":"/filing/0000904454-13-000399#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"SCHOEMAKER KATHLEEN K; DOMAIN PARTERS VII L P; BLAIR JAMES C; DOVEY BRIAN H; TREU JESSE I; Halak Brian K; VITULLO NICOLE","owner_display_name":"SCHOEMAKER KATHLEEN K","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12701.0,"shares_display":"12,701","price_per_share":5.22,"price_display":"5.22","price_state":"stated","total_value":66299.22,"total_display":"66,299.22","total_whole":"66,299","shares_owned_after":2483406.0,"shares_owned_after_display":"2,483,406","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-07","filed_date":"2013-03-11","scope":"insider"},{"id":5435107,"accession":"0000904454-13-000395","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000395","line_url":"/filing/0000904454-13-000395#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"VITULLO NICOLE; TREU JESSE I; DOVEY BRIAN H; BLAIR JAMES C; SCHOEMAKER KATHLEEN K; DOMAIN PARTERS VII L P; Halak Brian K","owner_display_name":"VITULLO NICOLE","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3839.0,"shares_display":"3,839","price_per_share":5.06,"price_display":"5.06","price_state":"stated","total_value":19425.34,"total_display":"19,425.34","total_whole":"19,425","shares_owned_after":2496107.0,"shares_owned_after_display":"2,496,107","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-06","filed_date":"2013-03-07","scope":"insider"},{"id":5145842,"accession":"0000904454-13-000388","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000904454-13-000388","line_url":"/filing/0000904454-13-000388#line-3","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"TREU JESSE I; SCHOEMAKER KATHLEEN K; Halak Brian K; VITULLO NICOLE; BLAIR JAMES C; DOVEY BRIAN H; DOMAIN PARTERS VII L P","owner_display_name":"TREU JESSE I","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":98349.0,"shares_display":"98,349","price_per_share":24.51,"price_display":"24.51","price_state":"stated","total_value":2410533.99,"total_display":"2,410,533.99","total_whole":"2,410,534","shares_owned_after":2740937.0,"shares_owned_after_display":"2,740,937","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-06","filed_date":"2013-03-06","scope":"insider"},{"id":5435103,"accession":"0000904454-13-000395","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000395","line_url":"/filing/0000904454-13-000395#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"VITULLO NICOLE; TREU JESSE I; DOVEY BRIAN H; BLAIR JAMES C; SCHOEMAKER KATHLEEN K; DOMAIN PARTERS VII L P; Halak Brian K","owner_display_name":"VITULLO NICOLE","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4039.0,"shares_display":"4,039","price_per_share":5.01,"price_display":"5.01","price_state":"stated","total_value":20235.39,"total_display":"20,235.39","total_whole":"20,235","shares_owned_after":2499946.0,"shares_owned_after_display":"2,499,946","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-05","filed_date":"2013-03-07","scope":"insider"},{"id":5145837,"accession":"0000904454-13-000388","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000388","line_url":"/filing/0000904454-13-000388#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"TREU JESSE I; SCHOEMAKER KATHLEEN K; Halak Brian K; VITULLO NICOLE; BLAIR JAMES C; DOVEY BRIAN H; DOMAIN PARTERS VII L P","owner_display_name":"TREU JESSE I","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":126868.0,"shares_display":"126,868","price_per_share":24.69,"price_display":"24.69","price_state":"stated","total_value":3132370.92,"total_display":"3,132,370.92","total_whole":"3,132,371","shares_owned_after":2839286.0,"shares_owned_after_display":"2,839,286","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-05","filed_date":"2013-03-06","scope":"insider"},{"id":5521379,"accession":"0000904454-13-000376","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000376","line_url":"/filing/0000904454-13-000376#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"TREU JESSE I; VITULLO NICOLE; DOVEY BRIAN H; SCHOEMAKER KATHLEEN K; BLAIR JAMES C; Halak Brian K; DOMAIN PARTERS VII L P","owner_display_name":"TREU JESSE I","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5145.0,"shares_display":"5,145","price_per_share":5.01,"price_display":"5.01","price_state":"stated","total_value":25776.45,"total_display":"25,776.45","total_whole":"25,776","shares_owned_after":2503985.0,"shares_owned_after_display":"2,503,985","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-04","filed_date":"2013-03-05","scope":"insider"},{"id":5145830,"accession":"0000904454-13-000388","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000388","line_url":"/filing/0000904454-13-000388#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"Clovis Oncology, Inc.","issuer_ticker":"CLVS","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"TREU JESSE I; SCHOEMAKER KATHLEEN K; Halak Brian K; VITULLO NICOLE; BLAIR JAMES C; DOVEY BRIAN H; DOMAIN PARTERS VII L P","owner_display_name":"TREU JESSE I","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24783.0,"shares_display":"24,783","price_per_share":24.44,"price_display":"24.44","price_state":"stated","total_value":605696.52,"total_display":"605,696.52","total_whole":"605,697","shares_owned_after":2966154.0,"shares_owned_after_display":"2,966,154","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-04","filed_date":"2013-03-06","scope":"insider"},{"id":5521378,"accession":"0000904454-13-000376","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000376","line_url":"/filing/0000904454-13-000376#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"TREU JESSE I; VITULLO NICOLE; DOVEY BRIAN H; SCHOEMAKER KATHLEEN K; BLAIR JAMES C; Halak Brian K; DOMAIN PARTERS VII L P","owner_display_name":"TREU JESSE I","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7635.0,"shares_display":"7,635","price_per_share":5.01,"price_display":"5.01","price_state":"stated","total_value":38251.35,"total_display":"38,251.35","total_whole":"38,251","shares_owned_after":2509130.0,"shares_owned_after_display":"2,509,130","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-03-01","filed_date":"2013-03-05","scope":"insider"},{"id":4762351,"accession":"0000904454-13-000315","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000315","line_url":"/filing/0000904454-13-000315#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DOVEY BRIAN H; VITULLO NICOLE; Halak Brian K; BLAIR JAMES C; DOMAIN PARTERS VII L P; TREU JESSE I; SCHOEMAKER KATHLEEN K","owner_display_name":"DOVEY BRIAN H","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1998.0,"shares_display":"1,998","price_per_share":5.01,"price_display":"5.01","price_state":"stated","total_value":10009.98,"total_display":"10,009.98","total_whole":"10,010","shares_owned_after":2516765.0,"shares_owned_after_display":"2,516,765","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-20","filed_date":"2013-02-22","scope":"insider"},{"id":4762347,"accession":"0000904454-13-000311","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000311","line_url":"/filing/0000904454-13-000311#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"Halak Brian K; SCHOEMAKER KATHLEEN K; DOMAIN PARTERS VII L P; TREU JESSE I; VITULLO NICOLE; BLAIR JAMES C; DOVEY BRIAN H","owner_display_name":"Halak Brian K","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10076.0,"shares_display":"10,076","price_per_share":5.02,"price_display":"5.02","price_state":"stated","total_value":50581.52,"total_display":"50,581.52","total_whole":"50,582","shares_owned_after":2518763.0,"shares_owned_after_display":"2,518,763","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-19","filed_date":"2013-02-20","scope":"insider"},{"id":4762343,"accession":"0000904454-13-000311","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000311","line_url":"/filing/0000904454-13-000311#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"Halak Brian K; SCHOEMAKER KATHLEEN K; DOMAIN PARTERS VII L P; TREU JESSE I; VITULLO NICOLE; BLAIR JAMES C; DOVEY BRIAN H","owner_display_name":"Halak Brian K","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2967.0,"shares_display":"2,967","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":14835.0,"total_display":"14,835.00","total_whole":"14,835","shares_owned_after":2528839.0,"shares_owned_after_display":"2,528,839","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-15","filed_date":"2013-02-20","scope":"insider"},{"id":4956273,"accession":"0000904454-13-000295","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000295","line_url":"/filing/0000904454-13-000295#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; SCHOEMAKER KATHLEEN K; Halak Brian K; TREU JESSE I; DOVEY BRIAN H; VITULLO NICOLE; DOMAIN PARTERS VII L P","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2951.0,"shares_display":"2,951","price_per_share":5.01,"price_display":"5.01","price_state":"stated","total_value":14784.51,"total_display":"14,784.51","total_whole":"14,785","shares_owned_after":2531806.0,"shares_owned_after_display":"2,531,806","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-14","filed_date":"2013-02-15","scope":"insider"},{"id":4956268,"accession":"0000904454-13-000295","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000295","line_url":"/filing/0000904454-13-000295#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"BLAIR JAMES C; SCHOEMAKER KATHLEEN K; Halak Brian K; TREU JESSE I; DOVEY BRIAN H; VITULLO NICOLE; DOMAIN PARTERS VII L P","owner_display_name":"BLAIR JAMES C","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5763.0,"shares_display":"5,763","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":28815.0,"total_display":"28,815.00","total_whole":"28,815","shares_owned_after":2534757.0,"shares_owned_after_display":"2,534,757","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-13","filed_date":"2013-02-15","scope":"insider"},{"id":5275525,"accession":"0000904454-13-000159","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000904454-13-000159","line_url":"/filing/0000904454-13-000159#line-1","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"SCHOEMAKER KATHLEEN K; VITULLO NICOLE; DOVEY BRIAN H; Halak Brian K; BLAIR JAMES C; DOMAIN PARTERS VII L P; TREU JESSE I","owner_display_name":"SCHOEMAKER KATHLEEN K","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9769.0,"shares_display":"9,769","price_per_share":4.85,"price_display":"4.85","price_state":"stated","total_value":47379.65,"total_display":"47,379.65","total_whole":"47,380","shares_owned_after":2540520.0,"shares_owned_after_display":"2,540,520","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-02-01","filed_date":"2013-02-05","scope":"insider"},{"id":5275522,"accession":"0000904454-13-000152","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000904454-13-000152","line_url":"/filing/0000904454-13-000152#line-2","is_derivative":false,"issuer_cik":"0001013425","issuer_name":"CADENCE PHARMACEUTICALS INC","issuer_ticker":"CADX","issuer_name_source":null,"issuer_url":"/issuer/0001013425","owner_cik":null,"owner_name":"DOMAIN PARTERS VII L P; SCHOEMAKER KATHLEEN K; DOVEY BRIAN H; Halak Brian K; VITULLO NICOLE; TREU JESSE I; BLAIR JAMES C","owner_display_name":"DOMAIN PARTERS VII L P","owner_url":null,"role":"Director, Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":7,"other_reporting_owners":6,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18537.0,"shares_display":"18,537","price_per_share":4.71,"price_display":"4.71","price_state":"stated","total_value":87309.27,"total_display":"87,309.27","total_whole":"87,309","shares_owned_after":2550289.0,"shares_owned_after_display":"2,550,289","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-01-31","filed_date":"2013-02-01","scope":"insider"}],"collapsed":true,"next_cursor":"2013-01-31|5275522","ledger_fault":false,"count":{"value":21,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":21,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":21},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001427570","name":"OBALON THERAPEUTICS INC","url":"/issuer/0001427570","role":"Ten percent owner","n_filings":2,"first_seen":"2018-08-27","last_seen":"2019-08-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001403708","name":"Evoke Pharma Inc","url":"/issuer/0001403708","role":"Ten percent owner","n_filings":7,"first_seen":"2015-04-16","last_seen":"2016-05-27"},{"type":"issuer","type_label":"ISSUER","cik":"0001311596","name":"Regado Biosciences Inc","url":"/issuer/0001311596","role":"Ten percent owner","n_filings":1,"first_seen":"2015-05-06","last_seen":"2015-05-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001618835","name":"Neothetics, Inc.","url":"/issuer/0001618835","role":"Ten percent owner","n_filings":2,"first_seen":"2014-11-26","last_seen":"2014-12-10"},{"type":"issuer","type_label":"ISSUER","cik":"0001434868","name":"Esperion Therapeutics, Inc.","url":"/issuer/0001434868","role":"Ten percent owner","n_filings":2,"first_seen":"2013-07-02","last_seen":"2014-10-21"},{"type":"issuer","type_label":"ISSUER","cik":"0001466301","name":"Clovis Oncology, Inc.","url":"/issuer/0001466301","role":"Ten percent owner","n_filings":3,"first_seen":"2011-11-21","last_seen":"2013-06-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001333248","name":"CADENCE PHARMACEUTICALS INC","url":"/issuer/0001333248","role":"Ten percent owner","n_filings":19,"first_seen":"2013-01-22","last_seen":"2013-04-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001382911","name":"Orexigen Therapeutics, Inc.","url":"/issuer/0001382911","role":"Ten percent owner","n_filings":12,"first_seen":"2008-12-11","last_seen":"2011-12-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001375151","name":"ZOGENIX, INC.","url":"/issuer/0001375151","role":"Ten percent owner","n_filings":2,"first_seen":"2010-12-01","last_seen":"2011-09-20"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001374150","retrieved_at":"2026-08-23T04:21:42+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}